Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1481 results found
2023 ∙ Limbu, Yam B. Gautam, Rajesh K.
The determinants of COVID-19 vaccination intention: a meta-review
All age groups Healthcare workers COVID-19 Acceptance
Rating:
Not applicable
2023 ∙ Wu, S. Wang, L. Dong, J. Bao, Y. Liu, X. Li, Y. Liu, X. Xie, H. Ying, H.
The Dose- and Time-Dependent Effectiveness and Safety Associated with COVID-19 Vaccination During Pregnancy: A Systematic Review and Meta-analysis
Pregnant women COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Low
2023 ∙ Chen, S. Y. Lin, C. Y. Chi, H. Weng, S. L. Li, S. T. Tai, Y. L. Huang, Y. N. Huang, H. Lin, C. H. Chiu, N. C.
The Effectiveness of Bivalent COVID-19 Vaccination: A Preliminary Report
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2023 ∙ Marra, A. R. Kobayashi, T. Callado, G. Y. Pardo, I. Gutfreund, M. C. Hsieh, M. K. Lin, V. Alsuhaibani, M. Hasegawa, S. Tholany, J. Perencevich, E. N. Salinas, J. L. Edmond, M. B. Rizzo, L. V.
The effectiveness of COVID-19 vaccine in the prevention of post-COVID conditions: a systematic literature review and meta-analysis of the latest research
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Khazanov, G. K. Stewart, R. Pieri, M. F. Huang, C. Robertson, C. T. Schaefer, K. A. Ko, H. Fishman, J.
The effectiveness of financial incentives for COVID-19 vaccination: A systematic review
All age groups COVID-19 Acceptance Economic aspects
Rating:
Not applicable
2023 ∙ Huang, Y. Huang, X. Yu, R.
The effectiveness of nonfinancial interventions and monetary incentives on COVID-19 vaccination: A meta-analysis
All age groups COVID-19 Acceptance Economic aspects
Rating:
Not applicable
2023 ∙ Xu, J. Lan, X. Zhang, L. Zhang, X. Zhang, J. Song, M. Liu, J.
The effectiveness of the first dose COVID-19 booster vs. full vaccination to prevent SARS-CoV-2 infection and severe COVID-19 clinical event: a meta-analysis and systematic review of longitudinal studies
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Critically low
2023 ∙ Al-Haideri, M. T. Mannani, R. Kaboli, R. Gharebakhshi, F. Darvishzadehdeldari, S. Tahmasebi, S. Faramarzi, F. Cotrina-Aliaga, J. C. Khorasani, S. Alimohammadi, M. Darvishi, M. Akhavan-Sigari, R.
The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease: A systematic review of clinical evidence
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Soheili, M. Khateri, S. Moradpour, F. Mohammadzedeh, P. Zareie, M. Mortazavi, S. M. M. Manifar, S. Kohan, H. G. Moradi, Y.
The efficacy and effectiveness of COVID-19 vaccines around the world: a mini-review and meta-analysis
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Yang, X. H. Bao, W. J. Zhang, H. Fu, S. K. Jin, H. M.
The Efficacy of SARS-CoV-2 Vaccination in the Elderly: A Systemic Review and Meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
Loading...